Does MOSUNETUZUMAB Cause Injection site reaction? 14 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 14 reports of Injection site reaction have been filed in association with MOSUNETUZUMAB (Lunsumio Velo). This represents 2.8% of all adverse event reports for MOSUNETUZUMAB.
14
Reports of Injection site reaction with MOSUNETUZUMAB
2.8%
of all MOSUNETUZUMAB reports
2
Deaths
9
Hospitalizations
How Dangerous Is Injection site reaction From MOSUNETUZUMAB?
Of the 14 reports, 2 (14.3%) resulted in death, 9 (64.3%) required hospitalization.
Is Injection site reaction Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for MOSUNETUZUMAB. However, 14 reports have been filed with the FAERS database.
What Other Side Effects Does MOSUNETUZUMAB Cause?
Cytokine release syndrome (96)
Disease progression (65)
Covid-19 (50)
Neutropenia (39)
Death (38)
Covid-19 pneumonia (37)
Malignant neoplasm progression (37)
Disorientation (31)
Neurological symptom (31)
Vasogenic cerebral oedema (31)
What Other Drugs Cause Injection site reaction?
ETANERCEPT (9,962)
ADALIMUMAB (4,375)
NALTREXONE (4,360)
DUPILUMAB (4,129)
GLATIRAMER (3,317)
IXEKIZUMAB (1,701)
METHOTREXATE (1,663)
TIRZEPATIDE (1,389)
TOCILIZUMAB (1,343)
CERTOLIZUMAB PEGOL (1,253)
Which MOSUNETUZUMAB Alternatives Have Lower Injection site reaction Risk?
MOSUNETUZUMAB vs MOSUNETUZUMAB-AXGB
MOSUNETUZUMAB vs MOXIFLOXACIN
MOSUNETUZUMAB vs MOXIFLOXACIN\MOXIFLOXACIN
MOSUNETUZUMAB vs MOXONIDINE
MOSUNETUZUMAB vs MS CONTIN